Independent Wealth Network’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,168
Closed -$235K 236
2023
Q4
$235K Buy
8,168
+236
+3% +$7.13K 0.12% 178
2023
Q3
$263K Buy
7,932
+69
+0.9% +$2.44K 0.16% 153
2023
Q2
$288K Buy
7,863
+58
+0.7% +$2.26K 0.17% 154
2023
Q1
$318K Buy
7,805
+426
+6% +$18.4K 0.2% 128
2022
Q4
$378K Buy
7,379
+317
+4% +$15.2K 0.26% 96
2022
Q3
$309K Sell
7,062
-189
-3% -$9.18K 0.24% 115
2022
Q2
$380K Sell
7,251
-617
-8% -$31.4K 0.27% 98
2022
Q1
$407K Buy
7,868
+76
+1% +$3.94K 0.26% 105
2021
Q4
$460K Sell
7,792
-1,127
-13% -$55.8K 0.28% 97
2021
Q3
$400K Buy
+8,919
New +$395K 0.26% 110

Other funds holding PFE

Independent Wealth Network's PFE Position: Q1 2024 in Review

Independent Wealth Network sold out of Pfizer (PFE) in Q1 2024, closing a stake of 8,168 shares — an estimated $235K sold.

Independent Wealth Network first reported a position in PFE in Q3 2021 and held it in 10 quarters. The position peaked at $460K in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Independent Wealth Network reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Independent Wealth Network sold 8,168 Pfizer shares in Q1 2024, an estimated $235K.
  • Independent Wealth Network first reported a position in Pfizer in Q3 2021 and held it in 10 quarters.
  • Independent Wealth Network's Pfizer position peaked at $460K in Q4 2021.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Independent Wealth Network's 13F filing for Q1 2024, filed 11 Apr 2024.